This company has been marked as potentially delisted and may not be actively trading. GlycoMimetics (GLYC) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrendsBuy This Stock Get the Latest News and Ratings for GLYC and Related Stocks Enter your email address to receive the latest news and analysts' ratings for GlycoMimetics and its competitors. Enter your email to sign up for newsletter Sign Up GLYC Analyst Ratings Over TimeTypeCurrent Forecast7/19/24 to 7/19/251 Month Ago6/19/24 to 6/19/253 Months Ago4/20/24 to 4/20/251 Year Ago7/20/23 to 7/19/24Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy1 Buy rating(s)1 Buy rating(s)1 Buy rating(s)0 Buy rating(s)Hold1 Hold rating(s)1 Hold rating(s)3 Hold rating(s)2 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price TargetN/AN/AN/A$1,000.00Forecasted UpsideN/AN/AN/A3,416.17% UpsideConsensus RatingModerate BuyModerate BuyHoldHold GLYC Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History GLYC Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table GlycoMimetics Stock vs. The CompetitionTypeGlycoMimeticsMedical CompaniesS&P 500Consensus Rating Score 2.50 2.82 2.53Consensus RatingModerate BuyModerate BuyModerate BuyPredicted UpsideN/A8,720.99% Upside11.45% UpsideNews Sentiment RatingNeutral NewsSee Recent GLYC NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails3/21/2025Cantor Fitzgerald3 of 5 starsEric SchmidtSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight7/26/2024TD Cowen4 of 5 starsT. BancroftSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold6/4/2024HC Wainwright1 of 5 starsE. WhiteSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral5/6/2024Capital One FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingN. QuibriaSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Equal WeightAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 04:38 PM ET. GLYC Forecast - Frequently Asked Questions Should I buy or sell GlycoMimetics stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GlycoMimetics in the last year. There is currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" GLYC shares. Does GlycoMimetics's stock price have much downside? According to analysts, GlycoMimetics's stock has a predicted downside of NaN based on their 12-month stock forecasts. Do Wall Street analysts like GlycoMimetics more than its competitors? Analysts like GlycoMimetics less than other "medical" companies. The consensus rating score for GlycoMimetics is 2.50 while the average consensus rating score for "medical" companies is 2.82. Learn more on how GLYC compares to other companies. Stock Forecasts and Research Tools Related Companies ATHE Stock Forecast PLUR Stock Forecast ITRM Stock Forecast STTK Stock Forecast HYPD Stock Forecast XLO Stock Forecast LVTX Stock Forecast KPTI Stock Forecast KALA Stock Forecast CGTX Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NASDAQ:GLYC) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlycoMimetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GlycoMimetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
